New peptide-based drugs for the treatment of neuropathic pain (2010–2012)

Abstract:
Chronic pain affects 1 in 5 Australians and neuropathic pain is among the most severe forms of chronic pain. Peptides from cone snail venoms have attracted recent attention as potential therapeutic agents for the treatment of neuropathic pain. Unfortunately, these peptides suffer from the disadvantage of short biological half-lives and poor activity when taken orally. We have developed a new approach to solve these problems that we will apply to develop new drugs for the treatment of pain.
Grant type:
NHMRC Project Grant
Researchers:
  • ARC Laureate Fellow - Group Leader
    Institute for Molecular Bioscience
    Affiliated Professor
    School of Biomedical Sciences
    Faculty of Medicine
  • Senior Research Fellow
    School of Biomedical Sciences
    Faculty of Medicine
    Affiliate ARC Future Fellow
    Institute for Molecular Bioscience
Funded by:
National Health and Medical Research Council